Biotech developing small-molecule treatments for Alzheimer's and neurodegenerative disease.
| Date | Round | Amount |
|---|---|---|
| Oct 2023 | Series A UK biotech AstronauTx raised a £48M Series A led by Novartis Venture Fund to advance Alzheimer's treatments. | $60M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.